How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials
|
VP of Clinical Development, HIV, Moupali Das shares
how the sponsor approaches diverse participant recruitment and enrollment,
highlighting the... |
Ministry approves long-acting HIV prevention drug for rollout
The injection is given once every six months and prevents HIV infection even in unprotected sex. View article...